Why is the HPV vaccine completion rate so low?

The completion rate for the human papillomavirus (HPV) vaccine series remains alarmingly low 7 years after its introduction in the US, say researchers at the University of Texas Medical Branch (UTMB). A series of three studies, published in Cancer, Human Vaccines & Immunotherapeutics and Vaccine used data from the 2010 National Health Interview Survey to show that more than 75% …